Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zastaprazan by Onconic Therapeutics for Corrosive Esophagitis (Erosive Esophagitis): Likelihood of Approval
Zastaprazan is under clinical development by Onconic Therapeutics and currently in Phase III for Corrosive Esophagitis (Erosive Esophagitis). According to...
Data Insights
Zastaprazan by Onconic Therapeutics for Gastric Ulcers: Likelihood of Approval
Zastaprazan is under clinical development by Onconic Therapeutics and currently in Phase III for Gastric Ulcers. According to GlobalData, Phase...